|
⚲
|
| Keyboard |
| Tierney David S
✚
|
|
|---|---|
| CIK # | 0001292636 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001292636] | |
| 4 | [0001292636] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catalyst Pharmaceuticals Inc | |
| Tierney David S | |
| Zevra Therapeutics Inc | |
| TREX Wind-Down Inc | |
| Bioject Medical Technologies Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-12-29 | Option exercise | 1,334 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-12-29 | Option exercise | 1,334 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-12-08 | Option exercise | 1,413 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-12-08 | Option exercise | 1,413 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-11-21 | Option exercise | 947 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-11-21 | Option exercise | 947 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2025-11-20 | Grant | 18,115 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-11-20 | Grant | 5,468 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2025-02-14 | Option exercise | 4,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2025-02-14 | Option exercise | 4,000 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-27 | Option exercise | 1,333 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-12-27 | Option exercise | 1,333 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Common Stock, par value $0.001 per share
|
2024-12-09 | Option exercise | 1,413 | ||
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-12-09 | Option exercise | 1,413 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2024-11-21 | Grant | 23,248 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Restricted Stock Units · derivative
|
2024-11-21 | Grant | 2,841 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Options to purchase common stock · derivative
|
2024-08-22 | Option exercise | 15,000 | $0.00 | |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2024-08-21 | Sell | 15,000 | $20.10 | 301,500 |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2024-08-21 | Option exercise | 15,000 | $4.01 | 60,150 |
|
Catalyst Pharmaceuticals Inc CPRX
Common stock, par value $0.001 per share
|
2024-04-08 | Option exercise | 25,000 | $4.01 | 100,250 |
| showing 20 of 109 most recent transactions | |||||